Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73976 - 74000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR297	100126354	upregulated	Silver results in increased expression of MIR297 mRNA	4q25	A24216
Silver	Approved Investigational	MIR299	407023	upregulated	Silver results in increased expression of MIR299 mRNA	14q32.31	A24216
Silver	Approved Investigational	MIR29B1	407024	upregulated	Silver analog results in increased expression of MIR29B1 mRNA	7q32.3	A24215
Silver	Approved Investigational	MIR29B1	407024	upregulated	Silver results in increased expression of MIR29B1 mRNA	7q32.3	A24216
Silver	Approved Investigational	MIR29B2	407025	downregulated	Silver results in decreased expression of MIR29B2 mRNA	1q32.2	A24216
Silver	Approved Investigational	MIR302A	407028	upregulated	Silver results in increased expression of MIR302A mRNA	4q25	A24215
Silver	Approved Investigational	MIR302B	442894	downregulated	Silver analog results in decreased expression of MIR302B mRNA	4q25	A24215
Silver	Approved Investigational	MIR302B	442894	downregulated	Silver results in decreased expression of MIR302B mRNA	4q25	A24215
Silver	Approved Investigational	MIR302C	442895	upregulated	Silver results in increased expression of MIR302C mRNA	4q25	A24216
Silver	Approved Investigational	MIR302D	442896	downregulated	Silver analog results in decreased expression of MIR302D mRNA	4q25	A24215
Silver	Approved Investigational	MIR302D	442896	downregulated	Silver results in decreased expression of MIR302D mRNA	4q25	A24215
Silver	Approved Investigational	MIR30C2	407032	downregulated	Silver results in decreased expression of MIR30C2 mRNA	6q13	A24216
Silver	Approved Investigational	MIR3144	100422951	upregulated	Silver results in increased expression of MIR3144 mRNA	6q22.31	A24216
Silver	Approved Investigational	MIR32	407036	downregulated	Silver analog results in decreased expression of MIR32 mRNA	9q31.3	A24215
Silver	Approved Investigational	MIR32	407036	upregulated	Silver results in increased expression of MIR32 mRNA	9q31.3	A24215
Silver	Approved Investigational	MIR33A	407039	downregulated	Silver analog results in decreased expression of MIR33A mRNA	22q13.2	A24215
Silver	Approved Investigational	MIR33B	693120	downregulated	Silver analog results in decreased expression of MIR33B mRNA	17p11.2	A24215
Silver	Approved Investigational	MIR362	574030	downregulated	Silver analog results in decreased expression of MIR362 mRNA	Xp11.23	A24215
Silver	Approved Investigational	MIR363	574031	downregulated	Silver results in decreased expression of MIR363 mRNA	Xq26.2	A24216
Silver	Approved Investigational	MIR379	494328	upregulated	Silver results in increased expression of MIR379 mRNA	14q32.31	A24216
Silver	Approved Investigational	MIR409	574413	upregulated	Silver results in increased expression of MIR409 mRNA	14q32.31	A24216
Silver	Approved Investigational	MIR411	693121	upregulated	Silver results in increased expression of MIR411 mRNA	14q32.31	A24216
Silver	Approved Investigational	MIR4253	100422914	upregulated	Silver results in increased expression of MIR4253 mRNA	1p36.12	A24216
Silver	Approved Investigational	MIR4286	100422982	downregulated	Silver results in decreased expression of MIR4286 mRNA	8p23.1	A24216
Silver	Approved Investigational	MIR4298	100423021	downregulated	Silver results in decreased expression of MIR4298 mRNA	11p15.5	A24216

Displaying entries 73976 - 74000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability